Abbreviations
- IL :
-
Interleukin
- GM-CSF :
-
Granulocyte-macrophage colony-stimulating factor
- CTL :
-
Cytotoxic T lymphocyte
- NK :
-
Natural killer
- LAK :
-
Lymphokine-activated killer
References
Blankenstein T, Li W, Müller W, Diamantstein T (1990) Retroviral interleukin-4 gene transfer into an interleukin-4 dependent cell line results in autocrine growth but not in tumorigenicity. Eur J Immunol 20:935–938
Blankenstein T, Qin Z, Überla K, Müller W, Rosen H, Volk H-D, Diamantstein T (1991) Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med 173:1047–1052
Böhm M, Möller P, Kalbfleisch U, Worm M, Czarnetzki BM, Schadendorf D (1994) Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells. Br J Cancer 70:54–59
Boon T, Coulie P, Marchand M, Weynants P, Wölfel T, Brichard V (1994) Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. In: DeVita VT, Hellman S, Rosenber SA (eds) Important advances in oncology 1994. Lippincott, Philadelphia, pp 53–69
Colombo MR, Gerrari G, Stoppacciaro A, et al (1991) Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173:889–897
Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539–3543
Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R und Gilboa E (1990) Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217–1224
Gansbacher B, Bannerji R, Daniels B, et al (1990) Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50:7820–7825
Ho VC, Sober AJ (1990) Therapy for cutaneous melanoma: an update. J Am Acad Dermatol 22:159–176
Hock H, Dorsch M, Diamantstein T, Blankenstein T. (1991). Inter-leukin-7 induces CD4+ T cell dependent tumor rejection. J Exp Med 174:1291–1298
Parkinson DR, Houghton AN, Hersey P, Borden EC (1992) Biologic therapy for melanoma: In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ (eds) Cutaneous melanoma. Lippincott, pp 522–541
Rosenberg SA (1994) Gene Therapy of Cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology 1994. Lippincott, Philadelphia, pp 17–38
Schadendorf D, Worm M, Czarnetzki BM (1993) Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation. J Cancer Res Clin Oncol 119:501–503
Schadendorf D, Böhm M, Möller P, Grünewald T, Czarnetzki BM (1994) Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells. J Invest Dermatol 102:838–842
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schadendorf, D., Czarnetzki, B.M. & Wittig, B. Interleukin-7, interleukin-12, and GM-CSF gene transfer in patients with metastatic melanoma. J Mol Med 73, 473–477 (1995). https://doi.org/10.1007/BF00202266
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00202266